Apixaban versus warfarin in patients with atrial fibrillation.

Granger CB, Alexander JH, McMurray JJ, Lopes RD, Hylek EM, Hanna M, Al-Khalidi HR, Ansell J, Atar D, Avezum A, Bahit MC, Diaz R, Easton JD, Ezekowitz JA, Flaker G, Garcia D, Geraldes M, Gersh BJ, Golitsyn S, Goto S, Hermosillo AG, Hohnloser SH, Horowitz J, Mohan P, Jansky P, Lewis BS, Lopez-Sendon JL, Pais P, Parkhomenko A, Verheugt FW, Zhu J, Wallentin L, ARISTOTLE Committees and Investigators

Open source

DOI
10.1056/nejmoa1107039
Published
2011 Sep 15
Container
The New England journal of medicine
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1056/nejmoa1107039,
  title = {Apixaban versus warfarin in patients with atrial fibrillation.},
  author = {Granger CB and Alexander JH and McMurray JJ and Lopes RD and Hylek EM and Hanna M and Al-Khalidi HR and Ansell J and Atar D and Avezum A and Bahit MC and Diaz R and Easton JD and Ezekowitz JA and Flaker G and Garcia D and Geraldes M and Gersh BJ and Golitsyn S and Goto S and Hermosillo AG and Hohnloser SH and Horowitz J and Mohan P and Jansky P and Lewis BS and Lopez-Sendon JL and Pais P and Parkhomenko A and Verheugt FW and Zhu J and Wallentin L and ARISTOTLE Committees and Investigators},
  year = {2011},
  journal = {The New England journal of medicine},
  doi = {10.1056/nejmoa1107039},
  url = {https://doi.org/10.1056/nejmoa1107039}
}

RIS

TY  - JOUR
TI  - Apixaban versus warfarin in patients with atrial fibrillation.
AU  - Granger CB
AU  - Alexander JH
AU  - McMurray JJ
AU  - Lopes RD
AU  - Hylek EM
AU  - Hanna M
AU  - Al-Khalidi HR
AU  - Ansell J
AU  - Atar D
AU  - Avezum A
AU  - Bahit MC
AU  - Diaz R
AU  - Easton JD
AU  - Ezekowitz JA
AU  - Flaker G
AU  - Garcia D
AU  - Geraldes M
AU  - Gersh BJ
AU  - Golitsyn S
AU  - Goto S
AU  - Hermosillo AG
AU  - Hohnloser SH
AU  - Horowitz J
AU  - Mohan P
AU  - Jansky P
AU  - Lewis BS
AU  - Lopez-Sendon JL
AU  - Pais P
AU  - Parkhomenko A
AU  - Verheugt FW
AU  - Zhu J
AU  - Wallentin L
AU  - ARISTOTLE Committees and Investigators
PY  - 2011
JO  - The New England journal of medicine
DO  - 10.1056/nejmoa1107039
UR  - https://doi.org/10.1056/nejmoa1107039
ER  - 

APA

CB, G., JH, A., JJ, M., RD, L., EM, H., M, H., HR, A., J, A., D, A., A, A., MC, B., R, D., JD, E., JA, E., G, F., D, G., M, G., BJ, G., S, G., S, G., AG, H., SH, H., J, H., P, M., P, J., BS, L., JL, L., P, P., A, P., FW, V., J, Z., L, W., & Investigators, A. C. A. (2011). Apixaban versus warfarin in patients with atrial fibrillation.. The New England journal of medicine. https://doi.org/10.1056/nejmoa1107039

Source records